Exploration of the pathogenesis of haemophilic joint arthropathy: Understanding implications for optimal clinical management

British Journal of Haematology

Volumn 156, Issue 1, 2012, Pages 13-23

  Acharya, Suchitra S ^a  

^a Northwell Health   (United States)

Author keywords

Cartilage; Haemarthroses; Haemophilia; Joint arthropathy; Synovium

Indexed keywords

AMINOCAPROIC ACID; ANALGESIC AGENT; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON; MYC PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN MDM2; ROFECOXIB; STROMAL CELL DERIVED FACTOR 1; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUPRESSURE; ACUPUNCTURE; ANGIOGENESIS; ARTHROPATHY; ARTHROPLASTY; BALNEOTHERAPY; CARDIOVASCULAR DISEASE; CARTILAGE INJURY; CHEMOPROPHYLAXIS; CHRONIC INFLAMMATION; CHRONIC PAIN; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG COST; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; EARLY DIAGNOSIS; ECHOGRAPHY; GENE; GENE MUTATION; HEMARTHROSIS; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIC JOINT ARTHROPATHY; HFE GENE; HUMAN; HYPERTHERMIC THERAPY; HYPNOSIS; JOINT ASPIRATION; MACROPHAGE; MASSAGE; MONOCYTE; MUCOSAL BLEEDING; MUSCLE TRAINING; NEUROFEEDBACK; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; SYNOVECTOMY;

HEMARTHROSIS; HEMOPHILIA A; HUMANS;

EID: 83555173200     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08919.x     Document Type: Review

References (88)

1. Acharya, S.S., Schloss, R., Dyke, J.P., Mintz, D.N., Christos, P., DiMichele, D.M. & Adler, R.S. (2008) Power Doppler sonography in the diagnosis of hemophilic synovitis - a promising tool. Journal of Thrombosis and Haemostasis, 6, 2055-2061.
2. Acharya, S.S., Kaplan, R.N., Macdonald, D., Fabiyi, O.T., DiMichele, D. & Lyden, D. (2011) Neoangiogenesis contributes to the development of hemophilic synovitis. Blood, 117, 2484-2493.
3. Aledort, L.M., Haschmeyer, R.H. & Pettersson, H. (1994) A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The orthopaedic outcome study group. Journal of Internal Medicine, 236, 391-399.
4. Arbini, A.A., Mannucci, P.M. & Bauer, K.A. (1995) Low prevalence of the factor V Leiden mutation among severe hemophiliacs with a milder bleeding diathesis. Thrombosis and Haemostasis, 74, 1255-1258.
5. Archer, C.W. & Francis-West, P. (2003) The chondrocyte. International Journal of Biochemistry and Cell Biology, 35, 401-404.
6. Arnold, W.D. & Hilgartner, M.W. (1977) Hemophilic arthropathy: current concepts of pathogenesis and management. Journal of Bone and Joint Surgery, 59, 287-305.
7. Astermark, J. (2006) Basic aspects of inhibitors to factors VIII and IX and the influence of non-genetic risk factors. Haemophilia, 12(Suppl. 6), 8-13.
8. Banta, J.V., Boone, D.C. & Smith, C.F. (1975) Arthrocentesis of the knee in acute hemophilic arthropathy. Western Journal of Medicine, 122, 285-288.
9. Beeton, K., Rodriguez-Merchan, E.C. & Alltree, J. (2000) Total joint arthroplasty in haemophilia. Haemophilia, 6, 474-481.
10. van den Berg, H.M., Fischer, K. & van der Bom, J.G. (2003) Comparing outcomes of different treatment regimens for severe haemophilia. Haemophilia, 9(Suppl. 1), 27-31. Discussion 31.
11. Brown, S.A., Aledort, L.M., Astermark, J., Berntorp, E., van den Berg, M., Blanchette, V., Donfield, S., Gringeri, A., Hilgartner, M., Kulkarni, R., Leissinger, C., Negrier, C., Nuss, R., Petterson, H., Petrini, P., Poulios, N. & Schramm, W. (2002) Unresolved issues in prophylaxis. Haemophilia, 8, 817-821.
12. Burkhardt, H., Schwingel, M., Menninger, H., Macartney, H.W. & Tschesche, H. (1986) Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis and Rheumatism, 29, 379-387.
13. Carroll, G.J., Breidahl, W.H. & Olynyk, J.K. (2011) Characteristics of the arthropathy described in hereditary hemochromatosis. Arthritis Care Research doi: (epub ahead of print).
14. Choiniere, M. & Melzack, R. (1987) Acute and chronic pain in hemophilia. Pain, 31, 317-331.
15. Collins, P.W., Blanchette, V.S., Fischer, K., Bjorkman, S., Oh, M., Fritsch, S., Schroth, P., Spotts, G.J., Astermark, J., Ewenstein, B. & On behalf of the RAHF-PFM Study Group (2009) Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. Journal Thrombosis Haemostasis, 7, 413-420.
16. Cruz, E., Porto, G., Morais, S., Campos, M. & de Sousa, M. (2005) HFE mutations in the pathobiology of hemophilic arthropathy. Blood, 105, 3381.
17. van Dijk, K., Fischer, K., van der Bom, J.G., Grobbee, D.E. & van den Berg, H.M. (2005) Variability in clinical phenotype of severe hemophilia: the role of the first joint bleed. Haemophilia, 11, 438-443.
18. DiMichele, D.M., Kroner, B. & the North American Immune Tolerance Study Group (2002) The North American immune tolerance registry: practice, outcomes and outcome predictors. Thrombosis and Haemostasis, 87, 52-57.
19. DiMichele, D.M., Goldberg, I., Foulkes, M. & Hay, C.R.M. (2010) International prospective randomized immune tolerance (ITI) study: preliminary results of therapeutic efficacy and safety. Haemophilia, 16(Suppl. 4), 29. (abstract).
20. Dunn, A.L., Busch, M.T., Wyly, J.B., Sullivan, K.M. & Abshire, T.C. (2004) Arthroscopic synovectomy for hemophilic joint disease in a pediatric population. Journal of Pediatric Orthopedics, 24, 414-426.
21. Ehrenforth, S., Kreutz, W. & Scharrer, I. (1992) Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet, 339, 594-598.
22. Fischer, K., van der Bom, J.G., Prejs, R., Mauser-Bunschoten, E.P., Roosendaal, G., Grobbee, D.E. & van den Berg, H.M. (2001) Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome. Haemophilia, 7, 544-550.
23. Fischer, K., van der Bom, J.G., Mauser-Bunschoten, E.P., Roosendaal, G., Prejs, R., de Kleijn, P., Grobbee, D.E. & van den Berg, M. (2002a) The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood, 99, 2337-2342.
24. Fischer, K., van der Bom, J.G., Molho, P., Negrier, C., Mauser-Bunschoten, E.P., Roosendaal, G., De Kleijn, P., Grobbee, D.E. & van den Berg, H.M. (2002b) Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome. Haemophilia, 8, 745-752.
25. Fischer, K., Valentino, L., Ljung, R. & Blanchette, V. (2008) Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors. Haemophilia, 14(Suppl. 3), 196-201.
26. Folkman, J. & Shing, Y. (1992) Angiogenesis. Journal of Biological Chemistry, 267, 10931-10934.
27. Garnero, P. (2008) Non invasive biochemical markers in osteoarthritis. In: Osteoarthritis (ed. by R.W. Moskowitz, R.D. Altman, M.C. Hochberg, J.A. Buckwalter & V.M. Goldberg), pp. 215-232. Wolters Kluwer Lippincott Williams & Wilkins, Philadelphia, PA.
28. Gerstner, G., Damiano, M.L., Tom, A., Worman, C., Schultz, W., Recht, M. & Stopeck, A.T. (2009) Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia. Haemophilia, 15, 559-565.
29. Gilbert, M.S. & Radomisli, T.E. (1997) Therapeutic options in the management of hemophilic synovitis. Clinical Orthopaedics and Related Research, 343, 88-92.
30. Hakobyan, N., Kazarian, T., Jabbar, A.A., Jabbar, K.J. & Valentino, L.A. (2004) Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. Blood, 104, 2060-2064.
31. Hakobyan, N., Kazarian, T. & Valentino, L.A. (2005) Synovitis in a murine model of human FVIII deficiency. Haemophilia, 11, 227-232.
32. Harris, S. & Boggio, L.N. (2006) Exercise may decrease further destruction in the adult haemophilic joint. Haemophilia, 12, 237-240.
33. Henry, D.A., Carless, P.A., Moxey, A.J., O'Connell, D., Stokes, B.J., Fergusson, D.A. & Ker, K. (2011) Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Systematic Reviews, (3): CD001886.
34. Heyworth, B.E., Su, E.P., Figgie, M.P., Acharya, S.S. & Sculco, T.P. (2005) Orthopedic management of hemophilia. American Journal of Orthopedics, 34, 479-486.
35. Hilberg, T., Herbsleb, M., Puta, C., Gabriel, H.H. & Schramm, W. (2003) Physical training increases isometric muscular strength and proprioceptive performance in haemophilic subjects. Haemophilia, 9, 86-93.
36. Hooiveld, M., Roosendaal, G., Vianen, M., van den Berg, H.M., Bijlsma, J.W. & Lafeber, F.P. (2003) Blood-induced joint damage: long-term effects in vitro and in vivo. Journal of Rheumatology, 30, 339-344.
37. Hoots, W.K. & Nugent, D.J. (2006) Evidence for the benefits of prophylaxis in the management of hemophilia A. Thrombosis and Haemostasis, 96, 433-440.
38. Ingerslev, J. & Hvid, I. (2006) Surgery in hemophilia: the general view: patient selection, timing, and preoperative assessment. Seminars in Hematology, 43(Suppl. 1), S23-S26.
39. Ingram, G.I., Mathews, J.A. & Bennett, A.E. (1972a) Controlled trial of joint aspiration in acute haemophilic haemarthrosis. Annals of the Rheumatic Diseases, 31, 423.
40. Ingram, G.I., Inglish, P.J. & Bennett, A.E. (1972b) Tranexamic acid for prophylaxis in haemophilia. Journal of Clinical Pathology, 25, 629.
41. Iorio, A., Fabbriciani, G., Marcucci, M., Brozzetti, M. & Filipponi, P. (2010) Bone mineral density in haemophilia patients. A meta-analysis. Thrombosis and Haemostasis, 103, 596-603.
42. Jansen, N.W., Roosendaal, G., Bijlsma, J.W., Degroot, J. & Lafeber, F.P. (2007) Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. Arthritis and Rheumatism, 56, 199-207.
43. Jansen, N.W.D., Roosendaal, G., Hooiveld, M.J.J., Bijlsma, J.W.J., van Roon, J.A.G., Theobald, M. & Lafeber, F.P.J.G. (2008) Interleukin-10 protects against blood-induced joint damage. British Journal of Haematology, 142, 953-961.
44. Jansen, N.W., Roosendaal, G., Lundin, B., Heijnen, L., Mauser-Bunschoten, E., Bijlsma, J.W., Theobald, M. & Lafeber, F.P. (2009) The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy. Arthritis and Rheumatism, 60, 290-298.
45. Journeycake, J.M., Miller, K.L., Anderson, A.M., Buchanan, G.R. & Finnegan, M. (2003) Arthroscopic synovectomy in children and adolescents with hemophilia. Journal of Pediatric Hematology Oncology, 25, 726-731.
46. Kern, M., Blanchette, V., Stain, A.M., Einarson, T.R. & Feldman, B.M. (2004) Clinical and cost implication of target joints in Canadian boys with severe hemophilia A. Journal of Pediatrics, 145, 628-634.
47. Khawaji, M., Astermark, J., Von Mackensen, S., Kesson, K.A. & Berntorp, E. (2011) Bone density and health-related quality of life in adult patients with severe haemophilia. Haemophilia, 17, 304-311.
48. Klamroth, R., Pollmann, H., Hermans, C., Faradji, A., Yarias, A.S., Epstein, J.D. & Ewenstein, B.M. (2011) The relative burden of hemophilia A and the impact of target joint development on health -related quality of life results from the ADVATE Post-Authorization Safety Surveillance (PASS) study. Haemophilia, 17, 412-421.
49. Lee, D.H., Walker, I.R., Teitel, J., Poon, M.C., Ritchie, B., Akabutu, J., Sinclair, G.D., Pai, M., Wu, J.W., Reddy, S., Carter, C., Growe, G., Lillicrap, D., Lam, M. & Blajchman, M.A. (2000) Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A. Thrombosis and Haemostasis, 83, 387-391.
50. Liesner, R.J., Khair, K. & Hann, I.M. (1996) The impact of prophylactic treatment on children with severe haemophilia. British Journal Haematology, 92, 973-978.
51. von Mackensen, S. (2007) Quality of life and sports activities in patients with haemophilia. Haemophilia, 13(suppl 2), 38-43.
52. Madhok, R., Bennett, D., Sturrock, R.D. & Forbes, C.D. (1988) Mechanisms of joint damage in an experimental model of hemophilic arthritis. Arthritis and Rheumatism, 31, 1148-1155.
53. Manco-Johnson, M.J., Abshire, T.C., Shapiro, A.D., Riske, B., Hacker, M.R., Kilkoyne, R., Ingram, J.D., Manco Johnson, M.L., Funk, S., Jacobson, L., Valentino, L.A., Hoots, W.K., Buchanan, G.R., DiMichele, D., Recht, M., Brown, D., Leissinger, C., Bleak, S., Cohen, A., Mathew, P., Matsunaga, A., Medeiros, D., Nugent, D., Thomas, G.A., Thompson, A.A., McRedmond, K., Soucie, J.M., Austin, H. & Evatt, B.L. (2007) Prophylaxis versus episodic treatment to prevnt joint disease in boys with severe haemophilia. New England Journal of Medicine, 357, 535-544.
54. Manco-Johnson, M.J., Nuss, R., Lear, J., Wiedel, J., Geraghty, S.J., Hacker, M.R., Funk, S., Kilcoyne, R.F. & Murphy, J. (2002) 32P Radiosynoviorthesis in children with hemophilia. Journal of Pediatric Hematology/oncology, 24, 534-539.
55. Mannucci, P.M. (1998) Hemostatic drugs. New England Journal of Medicine, 339, 245-253.
56. Morfini, M., Haya, S., Tagariello, G., Pollmann, H., Quintana, M., Siegmund, B., Stieltjes, N., Dolan, G. & Tusell, J. (2007) European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia, 13, 606-612.
57. Morris, C.J., Blake, D.R., Wainwright, A.C. & Steven, M.M. (1986) Relationship between iron deposits and tissue damage in the synovium: an ultrastructural study. Annals of Rheumatic Diseases, 45, 21-26.
58. Muir, H. (1995) The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays, 17, 1039-1048.
59. Nair, A.P., Jijina, F., Ghosh, K., Madhkaikar, M., Shrikhande, M. & Nema, M. (2007) Osteoporosis in young haemophiliacs from western India. American Journal of Hematology, 82, 453-457.
60. Nilsson, I.M. (1993) Experience with prophylaxis in Sweden. Seminars in Hematology, 30(suppl 2), 16-19.
61. Nilsson, I.M., Berntorp, E., Lofquist, T. & Pettersson, H. (1992) Twenty five years experience of prophylactic treatment in severe haemophilia A and B. Journal of Internal Medicine, 232, 25-32.
62. Nuss, R., Kilcoyne, R.F., Geraghty, S., Shroyer, A.L., Rosky, J.W., Mawhinney, S., Wiedel, J. & Manco-Johnson, M. (2000) MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage. Haemophilia, 6, 162-169.
63. Pipe, S.W. & Valentino, L.A. (2007) Optimizing outcomes for patients with severe haemophilia A. Haemophilia, 13(Suppl. 4), 1-16.
64. Plug, I., van der Bom, J.G., Peters, M., Mauser-Bunschoten, E.P., de Goede-Bolder, A., Heijnen, L., Smit, C., Zwart-van Rijkom, J.E., Willemse, J. & Rosendaal, F.R. (2004) Thirty years of hemophilia treatment in the Netherlands, 1972-2001. Blood, 104, 3494-3500.
65. Plug, I., Peters, M., Mauser-Bunschoten, E.P., de Goede-Bolder, A., Heijnen, L., Smit, C., Willemse, J., Rosendaal, F.R. & van der Bom, J.G. (2008) Social participation of patients with hemophilia in the Netherlands. Blood, 111, 1811-1815.
66. Rattray, B., Nugent, D.J. & Young, G. (2005) Rofecoxib as adjunctive therapy for hemophilic arthropathy. Haemophilia, 11, 240-244.
67. Remor, E., Arranz, P., Quintana, M., Villar, A., Jimenez-Yuste, V., Diaz, J.L., Rincón, C., Marrero, C., Moreno, M., Lucia, J.F., Martínez, E., Soto, I., Sedano, C., Gonzalez-Boullosa, R., Prieto, M., Garcia-Luaces, M., Hernández-Navarro, F. & Hemofilia-QoL Project Group (2005) Psychometric filed study of the new haemophilia quality of life questionnaire for adults: the hemofilia-QoL. Haemophilia, 11, 603-610.
68. Robertson, J.D., Connolly, B., Hilliard, P., Wedge, J., Babyn, P. & Carcao, M. (2009) Acute haemarthrosis of the hip joint: rapid convalescence following ultrasound-guided needle aspiration. Haemophilia, 15, 390-393.
69. Rodriguez-Merchan, E.C. (1996) Effects of haemophilia in articulations of children and adults. Clinical Orthopedic and Related Research, 328, 7-13.
70. Rodriguez-Merchan, E.C. (1997) Pathogenesis, early diagnosis and prophylaxis for chronic hemophilic synovitis. Clinics in Orthopedics, 343, 6-11.
71. Rodriguez-Merchan, E.C., Quintana, M., DeLa Corte-Rodriguez, H. & Coya, J. (2007) Radioactive synoviorthesis for the treatment of hemophilic synovitis. Haemophilia, 13(Suppl. 3), 32-37.
72. Roosendaal, G., Vianen, M.E., van den Berg, H.M., Lafeber, F.P. & Bijlsma, J.W. (1997) Cartilage damage as a result of hemarthrosis in a human in vitro model. Journal of Rheumatology, 24, 1350-1354.
73. Roosendaal, G., Vianen, M.E., Wenting, M.J., van Rinsum, A.C., van den Berg, H.M., Lafeber, F.P. & Bijlsma, J.W. (1998) Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. Journal of Bone and Joint Surgery, 80, 540-545.
74. Roosendaal, G., Vianen, M.E., Marx, J.J.M., Van Den Berg, H.M., Lafeber, F.P. & Bijlsma, J.W. (1999) Blood-induced joint damage: a human in vitro study. Arthritis and Rheumatism, 42, 1025-1032.
75. Sandell, I., Heinegard, D. & Hering, T. (2008) Cell biology, biochemistry and molecular biology of articular cartilage in osteoarthritis. In: Osteoarthritis (ed. by R.W. Moskowitz, R.D. Altman, M.C. Hochberg, J.A. Buckwalter & V.M. Goldberg), pp. 73-106. Wolters Kluwer Lippincott Williams & Wilkins, Philadelphia, PA.
76. Shapiro, A.D., Donfield, S.M., Lynn, H.S., Cool, V.A., Stehbens, J.A., Hunsberger, S.L., Tonetta, S., Gomperts, E.D. & Academic Achievement in Children with Hemophilia Study Group (2001) Defining the impact of hemophilia: the academic achievement in children with hemophilia study. Pediatrics, 108, e105.
77. So, A.K., Varisco, P.A., Kemkes-Matthes, B., Herkenne-Morard, C., Chobaz-Péclat, V., Gerster, J.C. & Busso, N. (2003) Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. Journal of Thrombosis and Haemostasis, 1, 2510-2515.
78. Soucie, J.M., Cainfrini, N., Janco, R.L., Kulkarni, R., Hambleton, J., Evatt, B., Forsyth, A., Geraghty, S., Hoots, K., Abshire, T., Curtis, R., Forsberg, A., Huszti, H., Wagner, M. & White, Jr, G.C. (2004) Joint range of motion limitations among young males with hemophilia: prevalence and risk factors. Blood, 103, 2467-2473.
79. Stein, H. & Duthie, R.B. (1981) The pathogenesis of chronic haemophilic arthropathy. Journal of Bone and Joint Surgery. British Volume, 63B, 601-609.
80. Sukeik, M., Alshryda, S., Haddad, F.S. & Mason, J.M. (2011) Systematic review and meta analysis of the use of tranexamic acid in total hip replacement. Journal of Bone and Joint Surgery, 93, 39-46.
81. Tagliaferri, A., Franchini, M., Coppola, A., Rivolta, G.F., Santoro, C., Rossetti, G., Feola, G., Zanon, E., Dragani, A., Iannaccaro, P., Radossi, P. & Mannucci, P.M. (2008) Effects of secondary prophylaxis started in adolescent and adult haemophiliacs. Haemophilia, 14, 945-951.
82. Tlacuilo-Parra, A., Villella Rodriguez, J., Garibaldi-Covarrubias, R., Sotopadilla, J. & Orozco-Alcala, J. (2011) Bone turnover markers and bone mineral density in children with haemophilia. Haemophilia, 17, 657-661.
83. Verma, N., Valentino, L.A. & Chawla, A. (2007) Arthroscopic synovectomy in hemophilia: indications, techniques and results. Haemophilia, 13, 38-44.
84. Wallny, T., Hess, L., Seuser, A., Zander, D., Brackmann, H.H. & Kraft, C.N. (2001) Pain status of patients with severe haemophilic arthropathy. Haemophilia, 7, 453-458.
85. Wen, F.Q., Jabbar, A.A., Chen, Y.X., Kazarian, T., Patel, D.A. & Valentino, L.A. (2002) c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide. Blood, 100, 912-916.
86. Wight, J. & Paisley, S. (2003) The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia, 9, 418-435.
87. Witkop, M., Lambing, A., Kachalsky, E., Divine, G., Rushlow, D. & Dinnen, J. (2011) Assessment of acute and persistent pain management in patients with haemophilia. Haemophilia, 17, 612-619.
88. Zukotynski, K., Jarrin, J., Babyn, P.S., Carcao, M., Pazmino-Canizares, J., Stain, A.M. & Doria, A.S. (2007) Sonography for assessment of haemophilic arthropathy in children: a systematic protocol. Haemophilia, 13, 293-304.